Shortages of rare nuclear isotopes that rapidly shrink tumours threaten to undermine the development of breakthrough treatments in which health companies have invested billions of dollars, experts in the nascent radiopharmaceuticals field have warned.
新興放射性藥物領域的專家警告稱，能迅速縮小腫瘤的稀有核同位素短缺，可能會威脅到醫療公司投資數十億美元的突破性治療方法的發展。
您已閱讀4%（314字），剩餘96%（8380字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。